Perceptive Advisors LLC and Joseph Edelman's Schedule 13G Filing for KALA BIO, Inc.

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 7.7% of the common stock of KALA BIO, Inc. The filing indicates that the Master Fund directly holds 543,745 shares of Common Stock. Perceptive Advisors serves as the investment manager to the Master Fund, and Joseph Edelman is the managing member of Perceptive Advisors. The filing certifies that the securities were not acquired for the purpose of influencing the control of the issuer. The event date requiring this filing was September 4, 2025, and the filing was submitted on September 11, 2025.